Restorative Streetscapes: Promoting Positive Mental Health Outcomes through Urban Landscape Design in Winooski, Vermont

The global health burden of mental health disorders is immense. The World Health Organization ranks depression as the single largest contributor to global disability; anxiety disorders alone rank sixth. One in four people will have a diagnosable mental illness in their lifetime and mental health conditions are increasing worldwide, rising 13% in the last decade. The economic implications are also immense, costing the global economy US $1 trillion each year. Mental health is more than the absence of disorders or disabilities, however. It is defined by the WHO as “a state of well-being in which an individual realizes his or her own abilities, can cope with the normal stresses of life, can work productively, and is able to make a contribution to his or her community.” Determinants of mental health include social, cultural, psychological, biological, economic, political, and environmental factors. Despite the complex interaction of contributing factors that determine an individual’s mental health condition, a growing body of research has found the built environment to be an important determinant (Evans 2003; Firdaus 2017; Satcher, Okafor, and Dill 2012). Streets are, in turn, the most prominent element of the urban public realm, and they represent an important opportunity to implement landscape-based features that may improve a community’s mental health and well-being. This project will generate a landscape design plan for streetscapes in Winooski, VT that strives to promote improved well-being and mental health for local residents. The city of Winooski was selected because it is the most ethnically diverse and one of the poorest towns in the state of Vermont (of towns with more than 2,000 people) according to the American Community Survey. Even though community mental health data is hard to access, low socio-economic status and ethnic minority neighborhoods are risk factors for poor mental health

Canada in Kandahar : an expression of internationalism

This thesis examines the decision by the government of Prime Minister Paul Martin in March of 2005 to deploy Canadian troops to the Kandahar region of Afghanistan – a region that is considered to be one of the most perilous in the country. Indeed, the Kandahar mission has produced the highest number of deaths of Canadians in combat since the Korean War. Prior to this engagement, the Chretien government had sent Canadian troops on other missions in Afghanistan, which neither were as dangerous nor involved combat against insurgents. This thesis will seek to provide an explanation for the change in policy under the Martin government. It will argue that the decision to engage Canada in combat in Afghanistan can be understood as an expression of internationalism, whose meaning had been altered by the forces of globalization growing out of the 9/11 attacks. The methodological approach that will be used in the thesis is a case study, which draws upon established theories regarding Canadian foreign policy

Monitoring and Modeling of Emissions from Concentrated Animal Feeding Operations: Overview of Methods

Accurate monitors are required to determine ambient concentration levels of contaminants emanating from concentrated animal feeding operations (CAFOs), and accurate models are required to indicate the spatial variability of concentrations over regions affected by CAFOs. A thorough understanding of the spatial and temporal variability of concentration levels could then be associated with locations of healthy individuals or subjects with respiratory ailments to statistically link the presence of CAFOs to the prevalence of ill health effects in local populations. This workgroup report, which was part of the Conference on Environmental Health Impacts of Concentrated Animal Feeding Operations: Anticipating Hazards—Searching for Solutions, describes instrumentation currently available for assessing contaminant concentration levels in the vicinity of CAFOs and reviews plume dispersion models that may be used to estimate concentration levels spatially. Recommendations for further research with respect to ambient air monitoring include accurately determining long-term average concentrations for a region under the influence of CAFO emissions using a combination of instruments based on accuracy, cost, and sampling duration. In addition, development of instruments capable of accurately quantifying adsorbed gases and volatile organic compounds is needed. Further research with respect to plume dispersion models includes identifying and validating the most applicable model for use in predicting downwind concentrations from CAFOs. Additional data are needed to obtain reliable emission rates from CAFOs

Placemaking in Metro East Springfield - Creating a Landscape Framework

PLACEMAKING IN METRO EAST SPRINGFIELD - Creating a Landscape Framework Placemaking in Metro East Springfield – Creating a Landscape Framework provides strategies to use the landscape as a framework for rebuilding community in a downtown urban area that has “good bones” but has been neglected and overlooked for decades. A catalyst for the development of project area is the recent acquisition of the historical 1916 Willys Overland building through a developer. The Graduate Urban Design Studio 2018 developed five proposals for urban revitalization in the area that are centered on the landscape. The programming of the proposals was developed in collaboration with neighborhood representatives and stakeholders of the area. The public response was very positive and the project got recognized in the local press and media. The Landscape Framework is interwoven with cultural activities such as public art and education, new opportunities for small neighborhood commerce, future employment and possibilities for new housing. The Landscape Framework will bring expand urban greening and will reduce heat island effects to reduce the impact of climate change. The presented Landscape Framework will guide the future of the area as overlapping and simultaneous measures. They encompass: Tangible tactile interventions on streets, facades and underutilized lots that change the perception of the landscape at low cost but are highly effective. New parks that create areas for recreation and contemplation. Greenway promenades connect to shorten long blocks and create a network to the neighboring residential areas. Establishment of urban agriculture activities to build community, provide food security and education. Collaboration with existing organizations in Springfield that are actively involved with urban agriculture: Gardening the Community (GTC) Springfield, Wellspring Harvest first commercial hydroponic greenhouse, UMass Extension and UMass Permaculture, Springfield Technical Community College (STCC). Walkable streets through extensive street tree plantings, widening of sidewalks, adding bicycle lanes and introducing shared multi-functional streets for community events. Stormwater Management through bioswales along streets, green roofs, larger infiltration areas in new parks and porous pavement. Promotion of alternative stormwater management through education and artistic interventions. People want to connect culturally and socially. Creating a sense of place, common ownership, and connectivity are a vital part of a sustainable community. This includes: Complimentary cultural, art, craft and education at new Maker-Spaces. Daycare Center and other childcare services. Outdoor pop-up business opportunities for food vendors such as food carts and trucks. Indoor pop-up business opportunities in abandoned or underutilized buildings. Adaptive reuse of existing architecture and infill. Diversification of housing market with inclusion of market-rate housing to create a more balanced economy. Legal framework through zoning changes and permitting that supports small businesses, reduces bureaucratic burdens and secures public open green space

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

BACKGROUND: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. METHODS: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). FINDINGS: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29-146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0- 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25-1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39-1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65-1·60]; p=0·92). INTERPRETATION: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention. FUNDING: British Heart Foundation

Reliable Software Updates for On-orbit CubeSat Satellites

CubeSat satellites have redefined the standard solution for conducting missions in space due to their unique form factor and cost. The harsh environment of space necessitates examining features that improve satellite robustness and ultimately extend lifetime, which is typical and vital for mission success. The CubeSat development team at Cal Poly, PolySat, has recently redefined its standard avionics platform to support more complex mission capabilities with this robustness in mind. A significant addition was the integration of the Linux operating system, which provides the flexibility to develop much more elaborate protection mechanisms within software, such as support for remote on-orbit software updates. This thesis details the design and development of such a feature-set with critical software recovery and multiple-mission single-CubeSat functionality in mind. As a result, features that focus on software update usability, validation, system recovery, upset tolerance, and extensibility have been developed. These include backup Linux kernel and file system image availability, image validation prior to boot, and the use of multiple file system devices to protect against system upsets. Furthermore, each feature has been designed for usability on current and future missions